Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK consults industry on neurostimulator vigilance

This article was originally published in Clinica

Executive Summary

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has issued draft guidance to manufacturers on the notification of adverse incidents involving neurostimulators. The guidance aims to "facilitate the uniform application and implementation" of medical devices directive 93/42/EEC, and is supplementary to the European Commission guidelines on the medical devices vigilance system and associated MHRA guidance. The consultation ends September 30 2009.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043991

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel